Synairgen plc
SYGGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.02 | 0.02 | -0.06 |
| FCF Yield | -172.16% | -103.99% | -69.24% | -9.93% |
| EV / EBITDA | -0.00 | 0.25 | -0.23 | -6.58 |
| Quality | ||||
| ROIC | -151.29% | -70.80% | -87.92% | -131.54% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.15 | 0.98 | 0.71 | 0.71 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 4.00% | 42.39% | 65.18% | -71.79% |
| Safety | ||||
| Net Debt / EBITDA | 0.55 | 1.03 | 0.79 | 0.59 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -28,933.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -25.50 | -18.42 |
| Cash Conversion Cycle | 0.00 | -2,572.38 | -1,975.29 | -7,800.86 |